Inmedix

Normandy Park, WA · Founded 2017 · Privately Held (backing)

Developer of a medical technology designed to assess autonomic nervous system function with clinical precision. Inmedix is based in Normandy Park, WA and was founded in 2017. It was valued at $33.5 million at its later-stage round in Nov 2024, the last priced event on record. It has raised $16.3 million across 3 recorded rounds; the latest was a $720,000 seed round in Aug 2024.

PMV mark · valuation
$33.5M
Oct 2026
Priced at
its later-stage round
Nov 2024
Total raised
$16.3M
Last round
Seed Round
Aug 2024

Inmedix key facts

as of Oct 2026
  • Developer of a medical technology designed to assess autonomic nervous system function with clinical precision.
  • Inmedix is valued at approximately $33.5M as of Oct 2026, set at its later-stage round, Nov 2024; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $16.3M across 3 recorded rounds; the latest was Seed Round ($720K) in Aug 2024.
  • Notable investors include Keiretsu Forum, Cairi Legacy Partners, Andrew Holman, Keiretsu Capital, NW Angel — 8 tracked in total.
  • Inmedix has filed 5 Form Ds with the SEC since 2021, most recently Oct 2025 ($160K sold to 4 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$33.5M

Valued at $33.5M at its later-stage round, Nov 2024. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Inmedix with a free account
  • ·Watch Inmedix: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Inmedix funding rounds

3 rounds
Aug 2024Seed Round$720KSEC filing▮
Mar 2022Seed Round$445KSEC filing▮
Mar 2021Debt$470KSEC filing▮

Inmedix valuation

Inmedix was valued at $33.5 million at its later-stage round in Nov 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Inmedix raised?

Inmedix has raised $16.3 million in total; 3 of its rounds are on record, from 2021 on. The largest on record was a $720,000 seed round in Aug 2024.

Inmedix has filed 5 Form Ds with the SEC since 2021, most recently in Oct 2025 ($159,980 sold to 4 investors).

Inmedix investors

8 investors are on record for Inmedix, including Keiretsu Forum, Cairi Legacy Partners, Andrew Holman and Keiretsu Capital. The seed round in Aug 2024 drew 5 investors.

About Inmedix

Developer of a medical technology designed to assess autonomic nervous system function with clinical precision. The company offers an FDA-cleared, payer-reimbursed CloudHRV System that quantifies parasympathetic and sympathetic activity in minutes, enabling healthcare providers to make informed decisions for improved patient care.

Sector
Healthcare
HQ
Normandy Park, WA, United States
Founded
2017
Employees
6
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.